Slovak Doctor Addresses Long-Standing Concerns About Cholesterol Drugs and Dementia Risk

A Slovak medical specialist has responded to persistent public concerns about whether cholesterol-lowering medications called statins increase the risk of dementia and other neurodegenerative diseases. Dr. Jan Piťha, who specializes in fat metabolism disorders, addressed a question from a 33-year-old patient named Adriana about the long-term risks of statin use. The concerns appear to stem from a 2009 study by researchers Beatrice Golomb from the University of California San Diego and colleague Mary Evans, which was based on patient self-reports rather than controlled clinical trials. The nearly two-decade-old research has continued to generate anxiety among patients considering or currently taking these widely prescribed medications for managing cholesterol levels.